Vasopressin in septic shock

Journal of the Intensive Care Society

Volumn 12, Issue 1, 2011, Pages 11-14

  Gordon, A C ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Acute kidney injury; Corticosteroids; Noradrenaline; Septic shock; Vasopressin

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; NORADRENALIN; PLACEBO; VASOPRESSIN; VASOPRESSIN V3 RECEPTOR;

ARTICLE; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; COMBINATION CHEMOTHERAPY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG WITHDRAWAL; ESOPHAGUS VARICES BLEEDING; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HUMAN; HYPONATREMIA; NONHUMAN; PRACTICE GUIDELINE; RECEPTOR UPREGULATION; SEPTIC SHOCK; SIDE EFFECT; SKIN DEFECT; VASOCONSTRICTION; VASODILATATION; VASOPRESSIN BLOOD LEVEL;

EID: 79954590087     PISSN: 17511437     EISSN: None     Source Type: Journal    
DOI: 10.1177/175114371101200105     Document Type: Article

References (28)

1. Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007;35: 33-40.
2. Landry D W, Levin HR, Gallant EM et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95: 1122-1125.
3. Sharshar T, Blanchard A, Paillard M et al. Circulating vasopressin levels in septic shock. Crit Care Med 2003;31:1752-1758.
4. Sharshar T, Carlier R, Blanchard A et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 2002;30:497-500.
5. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576-582.
6. Lauzier F, Levy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 2006;32:1782-1789.
7. Russell JA, Walley KR, Singer J et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-887.
8. Gordon AC, Russell JA, Walley KR et al. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med 2010;36:83-91.
9. Holmes CL, Walley KR, Chittock DR et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001;27:1416-1421.
10. Torgersen C, Dunser M W, Wenzel V et al. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial. Intensive Care Med 2010;36:57-65.
11. Russell JA, Walley KR, Gordon AC et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009;37:811-818.
12. Annane D. Vasopressin plus corticosteroids: the shock duo! Crit Care Med 2009;37:1126-1127.
13. Aguilera G, Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 2000;96:23-29.
14. Kuwahara S, Arima H, Banno R et al. Regulation of vasopressin gene expression by cAMP and glucocorticoids in parvocellular neurons of the paraventricular nucleus in rat hypothalamic organotypic cultures. J Neurosci 2003;23:10231-10137.
15. Lauand F, Ruginsk SG, Rodrigues HL et al. Glucocorticoid modulation of atrial natriuretic peptide, oxytocin, vasopressin and Fos expression in response to osmotic, angiotensinergic and cholinergic stimulation. Neuroscience 2007;147:247-257.
16. Kim JK, Summer SN, Wood WM, Schrier RW. Role of glucocorticoid hormones in arginine vasopressin gene regulation. Biochem Biophys Res Commun 2001;289:1252-1326.
17. Ertmer C, Bone HG, Morelli A et al. Methylprednisolone reverses vasopressin hyporesponsiveness in ovine endotoxemia. Shock 2007;27:281-288.
18. Bauer SR, Lam S W, Cha SS, Oyen LJ. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study. J Crit Care 2008;23:500-506.
19. Walley KR, Gordon AC, Russell JA. Hemodynamic effects of vasopressin versus norepinephrine in the VASST cohort. Am J Respir Crit Care Med 2007;175:A594.
20. Luckner G, Dunser M W, Jochberger S et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005;33: 2659-2666.
21. Dunser M W, Mayr AJ, Ulmer H et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 2001;93: 7-13.
22. Dunser M W, Mayr AJ, Ulmer H et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003;107:2313-2319.
23. van Haren FM, Rozendaal F W, van der Hoeven JG. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 2003;124:2256-2260.
24. Holmes CL, Landry D W, Granton JT. Science review: Vasopressin and the cardiovascular system part 1--receptor physiology. Crit Care 2003;7:427-434.
25. Haslam RJ, Rosson GM. Aggregation of human blood platelets by vasopressin. Am J Physiol 1972;223:958-967.
26. Mehta S, Granton J, Cook D et al. Troponin and CKMB trends in patients with septic shock randomized to vasopressin (VP) or Norepinephrine (NE). Am J Respir Crit Care Med 2009;179:A1564.
27. Gordon AC, Mehta S, Lapinsky S et al. Comparison of vasopressin-versus norepinephrine-associated ischemic ECG changes in septic shock. Intensive Care Med 2009;35:S114.
28. Gordon AC. ICS Research Prioritisation Exercise 2008; Vasopressin versus Noradrenaline as Initial therapy in Septic sHock. JICS 2009;10: 72-73.